Comparing Leflunomide vs Upadacitinib
Leflunomide | Upadacitinib |
|
---|
Leflunomide | Upadacitinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Psoriatic Arthritis, Rheumatoid Arthritis. Leflunomide may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Giant Cell Arteritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic... View more |
Related suggestions Rheumatoid Arthritis
|
|||||||
More about Leflunomide | More about Upadacitinib | ||||||||
Ratings & Reviews | |||||||||
Leflunomide has an average rating of 5.1 out of 10 from a total of 116 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 46% reported a negative effect. |
Upadacitinib has an average rating of 7.1 out of 10 from a total of 250 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Leflunomide side effects |
View all Upadacitinib side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Leflunomide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Arava | Rinvoq, Rinvoq LQ | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
336 hours |
14 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 686 drugs are known to interact with Leflunomide:
|
A total of 617 drugs are known to interact with Upadacitinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
September 10, 1998 |
August 16, 2019 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.